Klebsiella pneumoniae, a significant causative agent of community-acquired and nosocomial infections, is contributing to soaring morbidity and mortality rates. The problem is particularly pressing as rising antimicrobial resistance amongst K. pneumoniae strains continues to undermine effective treatment approaches. The situation calls for a thorough analysis and evaluation of initial antimicrobial therapies, 30-day all-cause mortality rates, and determinants of patient mortality, especially within the context of Lebanese healthcare institutions.
This article presents a multicenter retrospective observational study executed in three major university hospitals situated in Beirut, Lebanon. The research embraced confirmed K. pneumoniae infection cases in hospitalized adult patients and applied Kaplan-Meier survival analysis and log-rank tests for studying time-to-mortality. A binary logistic regression was employed to identify the mortality predictors.
Out of 2,655 examined cases, 395 were finalised in the analysis post exclusion of patients lost to follow-up. The 30-day mortality rate stood at 14.4% which illustrates the critical demand for enhanced antimicrobial stewardship and specialized infection control protocols to reduce resistance rates and positively shape patient outcomes. The study highlights the importance of monitoring local resistance patterns and using these metrics to guide the choice of suitable empirical therapy to lower morality related to K. pneumoniae infections.
K. pneumoniae, a Gram-negative bacterium, induces severe infections associated with high morbidity and mortality rates. The antimicrobial resistance patterns exhibited by K. pneumoniae are critical to consider in healthcare interventions, as complex resistance traits severely narrow the treatment options. The study’s findings underscore the exigency of novel antibiotics to combat health threats like multidrug-resistant K. pneumonia strains and emphasize the importance of appropriate initial antimicrobial therapy management.
The 30-day all-cause mortality rate and mortality predictors also need to be taken into account. For healthcare practitioners and policymakers in the field of infection prevention, consideration of these aspects is paramount in devising effective interventions and healthcare protocols going forward. The research strongly illustrates the pressing challenges surrounding K. pneumoniae and emphasizes the need for both long-term strategies and short-term actions towards robust infection control and antimicrobial stewardship.
Source: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-025-11010-5